Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Although the ability to offer compounded tirzepatide will phase out in early 2025, the demand for effective weight loss solutions is unlikely to wane
These numbers established tirzepatide as the most effective weight loss peptide available at the time of approval
No, As of 2026, retatrutide is still undergoing Phase 3 clinical trials under the TRIUMPH program
Reduced appetite means fewer opportunities to consume nutrients, making food quality more important than ever
Studies in the National Library of Medicine suggest that GLP-1 medications can improve menstrual regularity and ovulation, reduce insulin resistance and androgen levels, and support spontaneous pregnancy after a period of treatment
Lilly's retatrutide delivered up to 24% weight loss in phase 2 obesity study
US$ 25.67
US$ 24.64
US$ 21.61
US$ 20.98
US$ 20.67
.webp)
US$ 23.29
